• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Oriola

0.91 EUR

-1.09 %

7,749 following

ORIOLA

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.09 %
-1.19 %
-12.24 %
-20.78 %
-17.78 %
-16.73 %
-33.01 %
-50.38 %
-50.47 %

Oriola is a pharmaceutical group with a particular focus on the distribution of pharmaceuticals to other players in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest operations are in the Nordic and Baltic regions. The headquarters are located in Espoo.

Read more
Market cap
168.83M EUR
Turnover
232.12K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Accumulate
Target price
Updated
30.04.2026
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
There have been changes in the ownership of the Swedish pharmacy company half-owned by Oriola. The Lithuanian owner of the other half has sold its stake in the Swedish pharmacy company from the Euroapotheca Group, which operated pharmacy activities, to another group company. Euroapotheca...
5/9/2026, 8:19 AM
by Aktivisti26
10
Quite valid points, largely the same issues I have raised regarding this myself. Coincidentally, I was just reviewing Oriola, so let’s include one image here that shows in a rather stark way how Kronans Apotek’s profitability has melted away, even though the 2022 merger should have...
5/22/2026, 7:26 AM
by Rauli_Juva
7
Rauli interviewed Oriola’s CFO Mats Danielsson Topics: 00:00 Introduction 00:13 Mats Danielsson 01:28 Key points of the updated strategy 05:48 Changes in strategy 06:38 Financial targets 07:41 Growth target 09:19 Profitability target 13:44 Investments 15:01 Associated company Kronans...
5/18/2026, 8:40 PM
by Sijoittaja-alokas
6
Let’s share this Jussi Halme video about Oriola here; the man usually talks a lot of sense. I haven’t had the chance to listen to it myself yet, but maybe it resonates with someone’s thoughts: https://www.youtube.com/watch?v=3orteSq7eXE
5/22/2026, 5:59 AM
by NukkeNukuttaja
5
Here are Rauli’s pre-event comments regarding Oriola’s CMD festivities to be held on May 12th Oriola already announced its new financial targets in connection with the Q1 results, which will be further presented at the Capital Markets Day on May 12th. We would particularly seek clarity...
5/11/2026, 5:11 AM
by Sijoittaja-alokas
4
Here are Evli’s thoughts on Oriola. Oriola started of the year with a lower-than-expected improvement in adj. EBITDA due to performance of the advisory business and elevated group costs, but we expect performance to pick up during the year. ACCUMULATE with a target price of EUR 1...
5/3/2026, 2:12 PM
by Sijoittaja-alokas
4
Here are Rauli’s quick comments on Oriola’s Q1 result. Oriola’s adj. EBITDA improved from the comparison period but fell short of our expectations. The result of the associate company Kronans continued to be loss-making and was also weaker than our expectations. As expected, the ...
4/29/2026, 8:07 AM
by Sijoittaja-alokas
4
Read more on our forum
Rauli Juva
Rauli Juva

Analyst

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7.
2026

Interim report Q2'26

29.10.
2026

Interim report Q3'26

Regulatory press release5/29/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 22, 2026

Oriola
Regulatory press release5/22/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 21, 2026

Oriola
Regulatory press release5/15/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 20, 2026

Oriola

Join Inderes community

Research, tools and community to support better investment decisions.

FREE account
The market's most popular morning review
Analysts' recommendations and comments
Stock comparison and the investor discussion forum
PREMIUM account
All company reports and analyses
Premium content: model portfolio, insider transactions, Premium articles
Inderes MCP: Inderes data directly into your AI tools
Create account
Third party research5/13/2026, 6:43 AM

Oriola: Solid mid-term potential - Evli

With the financial targets announced earlier along with major investments known, Oriola’s CMD was limited in terms of significant new news, which we see as a positive given earlier concerns. More clarity was however provided on the roadmap to achieving...

Oriola
Press release5/11/2026, 10:00 AM

Oriola Oyj: Oriola focuses on profitable growth and value creation at Capital Markets Day

Oriola
Regulatory press release5/8/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 19, 2026

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Pajamo

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Axdorff

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Westerlund

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Carlsson Meyer

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Närhinen

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Nilsson

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Pärssinen

Oriola
Third party research4/30/2026, 6:43 AM

Oriola: Soft start but expecting improvement - Evli

Oriola started of the year with a lower-than-expected improvement in adj. EBITDA due to performance of the advisory business and elevated group costs, but we expect performance to pick up during the year.

Oriola
Third party research4/29/2026, 7:31 AM

Oriola: Softer profitability, good growth - Evli

Oriola posted fairly decent figures in Q1. Net sales and invoicing growth continued at a good pace, with the latter up 8.1% y/y. The adj. EBITDA of EUR 7.7m fell well short of our EUR 8.5m expectations, with profitability in the Services-segment declining...

Oriola
Oriola, Webcast, Q1'26
Webcast4/29/2026, 7:00 AM

Oriola, Webcast, Q1'26

Oriola
Regulatory press release4/29/2026, 5:40 AM

Oriola Oyj: Oriola commences a share buyback programme

Oriola
Regulatory press release4/29/2026, 5:35 AM

Oriola Oyj: Oriola's new financial targets and dividend policy

Oriola
Regulatory press release4/29/2026, 5:30 AM

Oriola Oyj: Oriola Corporation's Interim Report 1 January-31 March 2026

Oriola
Third party research4/28/2026, 5:46 AM

Oriola: Expecting steady progress - Evli

Oriola reports its Q1 results on April 29th. We expect continued improvement in adj. EBITDA. We have lowered our coming year profitability estimates and adjust our target price to EUR 1.0 (1.15), ACCUMULATE-rating intact.

Oriola